VLA viralytics limited
Add to My Watchlist 0.00% ! $1.75

wish i was a medico, page-5

  1. milward
    89 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    09/04/14
    12:51
    Post #: 13231529
    Amgen misses its survival goal in the melanoma phase 3 trial.
    Amgen said T-VEC hits its primary endpoint of durable response in patients with metastatic melanoma but missed its second goal of boosting overall survival.
    VLA Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump just dropped a 200% tariff bomb. Here's how to cash in
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
NEWS Blue Moon first wedge hole intersects 543g/t gold over 1.2m in laminated quartz vein
right-arrow Created with Sketch.
NEWS Mandalay Resources Discovers High-Grade Skarn and Provides Update on Near Mine Exploration at Björkdal
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.